Literature DB >> 36053466

Differential gene expression analysis of common target genes for the detection of SARS-CoV-2 using real time-PCR.

Reza Valadan1,2, Soheila Golchin3, Reza Alizadeh-Navaei3, Mohammadreza Haghshenas4, Mehryar Zargari5, Tahoora Mousavi6,7, Mohammad Ghamati8.   

Abstract

COVID-19 currently is the main cause of the severe acute respiratory disease and fatal outcomes in human beings worldwide. Several genes are used as targets for the detection of SARS-CoV-2, including the RDRP, N, and E genes. The present study aimed to determine the RDRP, N, and E genes expressions of SARS-CoV- 2 in clinical samples. For this purpose, 100 SARS-CoV-2 positive samples were collected from diagnostic laboratories of Mazandaran province, Iran. After RNA extraction, the real-time reverse transcription PCR (real-time RT-PCR) assay was performed for differential gene expressions' analysis of N, E, and RDRP. The threshold cycle (Ct) values for N, RDRP, and E targets of 100 clinical samples for identifying SARS-CoV-2 were then evaluated using quantitative real-time PCR (qRT-PCR). This result suggests N gene as a potential target for the detection of the SARS-CoV-2, since it was observed to be highly expressed in the nasopharyngeal or oropharynges of COVID-19 patients (P < 0.0001). Herein, we showed that SARS-CoV- 2 genes were differentially expressed in the host cells. Therefore, to reduce obtaining false negative results and to increase the sensitivity of the available diagnostic tests, the target genes should be carefully selected based on the most expressed genes in the cells.
© 2022. The Author(s).

Entities:  

Keywords:  And E genes expressions; N; RDRP; RT -PCR assay; SARS-CoV-2

Year:  2022        PMID: 36053466      PMCID: PMC9438354          DOI: 10.1186/s13568-022-01454-2

Source DB:  PubMed          Journal:  AMB Express        ISSN: 2191-0855            Impact factor:   4.126


Introduction

COVID-19, which is currently known as the global pandemic of Coronavirus, is responsible for the severe acute respiratory disease and fatal outcomes in human beings worldwide (Korber et al. 2020). Coronaviruses as a group of enveloped viruses with positive-sense single-stranded RNA belong to the family Coronaviridae, which are able to spread between humans and animals (Holshue et al. 2020). Unlike HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1 to cause moderate upper respiratory infection in human (Hu et al. 2014), three previous epidemics of β-coronaviruses such as Middle East respiratory syndrome-related Coronavirus (MERS-CoV), severe acute respiratory syndrome Coronavirus (SARS-CoV), and severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), have been potentially associated with acute respiratory distress syndrome (ARDS) with about 35.5%, 9.6%, and 6.76% mortality rates, respectively (Lu et al. 2020). SARS-CoV-2 contains open reading frames (ORFs) that encode four structural proteins, including S-spike, M-membrane, E-envelope, and N-nucleocapsid. Of note, several genes are used as the targets gene for detection of SARS-CoV-2 such as the (RDRP and S), (N and S), and E genes. In this regard, studies have previously shown that N protein is produced in large quantities in infected cells, which is related to the processes of replication, translation, and transcription. Moreover, it causes cell cycle deregulation, consequently inhibiting interferon production and inducing apoptosis (Astuti 2020). The RNA-dependent RNA polymerase, called ORF1ab, is responsible for viral transcription and replication. Therefore, RT-PCR based 2 target genes (ORF1ab and N) are the crucial targets for SARS-CoV-2 detection (Shen et al. 2021). In order to have the best RT-PCR performance, the components of these targets should be optimized (Tombuloglu et al. 2021). Accordingly, reverse transcription polymerase chain reaction (RT-PCR) using fluorescent dyes is considered as a gold standard method for detecting bacterial and viral nucleic acid (DNA / RNA). RT-q PCR can also be used as a rapid and accurate assay for screening SARS-CoV-2 in throat samples, nasopharyngeal swabs, and feces (Chaimayo et al. 2020). A cohort study has shown that RT-PCR with sensitivity and specificity values of 70% and 95% could detect viruses in patients, even in those showing no symptoms (Arevalo-Rodriguez et al. 2020; Rutuja Sunil and Vasudeo Pandharinath 2021). However, a successful detection of this virus depends on some factors such as test time, early or late detection time, viral load, and sample collection procedure (Vickers 2017). The ORF1ab/RdRp, E, N, and S genes most commonly used targets for detection of SARS-CoV-2 so, there are some commercial RT-PCR kits for the diagnosis of COVID-19 such as Primer Design (England, RdRp), Seegene (Korea, RdRp, N, E), CerTest Biotec (Spain, ORF1ab, N), Altona Diagnostics (Germany, S, E), BGI (China, ORF1ab), KH Medical (Korea, RdRp, S), and R-Biopharm AG (Germany, E) with different qualities, which are available to be used for the diagnosis of SARS-CoV-2 (Puck et al. 2020). According to this point that diagnosis of SARS-CoV-2 infection with two or three targets lead to an increase in sensitivity and specificity and avoid a false negative result, so the present study attempted to analyze the RDRP, N, and E genes expressions of SARS-COV- 2 using qRT-PCR through specific primer pairs in the obtained clinical samples.

Materials and methods

Simplex primer and probe design

The specific qRT-PCR primers and probe for the diagnosis of the target regions of the SARS-​CoV-2 were designed using the following programs: PrimerPooler, PrimerPlex, and Primer3 (Tombuloglu et al. 2021). Moreover, 5’ Fluorescein amidites (FAM)-labeled probe was designed for the SARS-CoV-2 RdRp/ N/RP, as well as Hypoxanthine Phosphoribosyltransferase (HPRT) and Yakkima yellow-labeled probe for the viral E gene, which were then synthesized (Fig. 1). The sequence of each primer or probe is shown in Table 1.
Fig. 1

Experimental design of qRT-PCR

Table 1

The sequences and concentrations of primer and probe sets used in the PCR reactions

TargetSequence(5′-3′)LabelReference
2019-nCoV_N1-FGAC CCC AAA ATC AGC GAA ATNone(Jung et al. 2020)
2019-nCoV_N1-RCT GGT TAC TGC CAG TTG AAT CTGNone(Jung et al. 2020)
2019-nCoV_N1-PFAM-ACC CCG CAT TAC GTT TGG TGG ACC-BHQ1FAM, BHQ1(Bruce et al. 2020)
E_Sarbeco_F1ACAGGTACGTTAATAGCGTNone(Corman et al. 2020a)
E_Sarbeco_R1ATATTGCAGCAGTACGCACACANone(Corman et al. 2020a)
E_Sarbeco_PYakkima yellow-ACACTAGCCATCCTTACTGCGCTTCG-BHQ1Yakkima yellow, BHQ1(Corman et al. 2020a)
2019-nCoV_ RDRP-F1GTGARATGGTCATGTGTGGCGGNone(Corman et al. 2020a)
2019-nCoV_ RDRP-RCARATGTTAAASACACTATTAGCATANone(Corman et al. 2020a)
2019-nCoV_ RDRP-PFAM-CAGGTGGAACCTCATCAGGAGATGC-BHQ1FAM, BHQ1(Corman et al. 2020a)
HPRT-FGGACTAATTATGGACAGGACTGNone(Valadan et al. 2015a)
HPRT-RGCTCTTCAGTCTGATAAAATCTACNone(Valadan et al.2015a)
HPRT-PFAM-CCTCCCATCTCCTTCATCACATCTC–BHQ1FAM, BHQ1(Valadan et al. 2015a)
RP-FAGA TTT GGA CCT GCG AGC GNone(Gregianini et al. 2019)
RP-RGAG CGG CTG TCT CCA CAA GTNone(Gregianini et al. 2019)
RP-PFAM – TTC TGA CCT GAA GGC TCT GCG CG – BHQ-1FAM, BHQ1(Gregianini et al. 2019)
Experimental design of qRT-PCR The sequences and concentrations of primer and probe sets used in the PCR reactions

RNA extraction from the clinical samples

The study was approved by the Mazandaran University of Medical Sciences, Iran, with the number IR.MAZUMS.REC.1399.8671. For the purpose of this study, Nasopharyngeal and oropharyngeal swabs were collected from symptomatic patients, immediately diluted with viral transfer medium (VTM), and finally transferred to the COVID-19 laboratory at Mazandaran University of Medical Sciences for the detection of SARS-CoV-2. RNA extraction was performed in 100 positive samples using the RNJia virus kit (Jivan, Iran) in terms of the manufacturer’s instructions. Subsequently, the differential gene expressions of N, E, and RdRp were performed using qRT-PCR.

Real-time RT-PCR assay

In this study, 20-µL reaction containing 4 µL of RNA, 10 µL of one step RT-PCR kit(add bio, korea), 2 µL of enzyme mixture, 0.5 µL of forward and reverse primers, 0.5 µL of each probe, and RNase/DNase-free ddH2O up to 20 µL, was setup. Final primers and probes concentrations in the reaction were adjusted using the following steps: 1.0.25 pM for RdRP-F, and 0.25 pM for RdRP-R. 2. 0.25 pM for E-F, and 0.25 pM for E-R. 3. 0.25 pM for N-F, and 0.25 pM for N-R. 4. 0.25 pM for HPRT-F, and 0.25 pM for HPRT-R. The reaction was dispensed in 96-well microplates (MicroAmp™ Fast Optical 96-well reaction Plate 0.1 mL, Applied Biosystems) and then sealed with optical film (MicroAmp™ Optical Adhesive Film, Applied Biosystems). Of note, a negative control reaction (RNase/DNasefree ddH2O) was used to check the presence of any contamination. In addition, HPRT and RP genes were used as internal controls (Valadan et al. 2015b). Thereafter, Quantitation experiments were conducted using RT-PCR instrument (StepOne™ Real-Time PCR System). As well, qPCR was performed as follows: Reverse transcription was performed for 20 min at 50 °C, Inactivation of the reverse transcriptase was done for 10 min at 95 °C. PCR amplification was performed with 40 cycles for 15 s at 95 °C and for 30 s at 58 °C using StepOne™ Real-Time PCR.

Statistical analysis

The obtained results were examined by determining the amplification curve of the target gene and the housekeeping gene. Continuous variables are indicated as means (standard deviation, SD). All the statistical analyses were performed using GraphPad Prism 8 software and p-values less than 0.001 were considered as statistically significant.

Results

In the present study, 100 respiratory samples were collected from nasopharyngeal (NP) and throat swabs in health-care centers of Mazandarn, Iran, from December 2020 to September 2021. Thereafter, Real-time RT-PCR, using E, RDRP, and N targets, was performed for genome detection of SARS-CoV-2. Firstly, all the primers and probes were analyzed by simplex qRT-PCR. Prior to preparing the reactions, the qRT-PCR instrument was properly calibrated in order to achieve the best fluorescent signal. The simplex reactions were then performed in triplicate for three viral E, N, and RDRP genes as well as internal control genes (HPRT and RP). The criteria for the diagnosis of positive, negative, and suspicious COVID-19 samples were as follows: (0 < Ct < 37.00), (NO Ct or Ct ≥ 40.00), and (37.00 ≤ Ct < 40.00), respectively. The average cycle threshold (Ct) and ∆Ct value with standard deviations (SD) are shown in Tables 2 and 3, and the comparative Ct performances of each assay are shown in Figs. 2 and 3. In this research, HPRT and RP genes were used as internal controls. Indeed HPRT and RP had significantly increased expression level compared to other targets (including N, E, and RDRP) (P < 0.0001). Our findings showed that no detectable difference exists between HPRT and RP internal controls. According to the comparison of ∆Ct values among N, E, and RDRP targets, the N gene expression level was found to be higher than that of E and RDRP genes. (P < 0.0001). As shown in Fig. 4, there is no significant difference between E and N targets (0.611). The result of our study suggest N gene as the most sensitive target compared to E and RDRP for SARS-CoV-2 detection using RT-PCR.
Table 2

The Ct value emerged in RT-PCR assay for the SARS-COV-2

CharacteristicsResult

Ct-value of E

Mean ± SD (min, max)

26 ± 6.53

(14.24, 39.24)

Ct-value of N

Mean ± SD (min, max)

20.19 ± 5.93

(9.72, 33.82)

Ct-value of RDRP

Mean ± SD (min, max)

26.92 ± 7.04

(13.85, 40)

Ct-value of HPRT

Mean ± SD (min, max)

31.34 ± 2.75

(26.94, 40)

Ct-value of RP

Mean ± SD (min, max)

24.43 ± 1.63

(20.56, 27.94)

Table 3

The ∆Ct value emerged in RT-PCR assay for the SARS-COV-2.

Characteristics∆Ct value(HPRT control)∆Ct value (RP control)

E gene

Mean ± SD (min, max)

−5.34 ± 6.76

(−15.15, 0)

1.57 ± 6.74

(−8.71, 19.07)

N gene

Mean ± SD (min, max)

−11.15 ± 6.28

(−22.45, 0.43)

−4.23 ± 6.13

(−13.23, 13.65)

RDRP gene

Mean ± SD (min, max)

−4.42 ± 7.27

(−16.91, 11.42)

2.49 ± 7.32

(−6.84, 17.59)

Fig. 2

Cycle threshold (Ct) value of qRT-PCR. HPRT gene was used as an internal control. A Comparison of N target and HPRT, B Comparison of E target and HPRT, and C Comparison of RDRP target and HPRT. A significant difference is indicated by *P < 0.05. **** = (< 0.0001).

Fig. 3

Cycle threshold (Ct) value of qRT-PCR. RP gene was used as an internal control. A Comparison of N target and RP, B Comparison of E target and RP, and C Comparison of RDRP target and RP. A significant difference is indicated by *P < 0.05. **** = (< 0.0001).

Fig. 4

Comparison of the cycle threshold (∆Ct) value of SARS-COV-2 expression. A HPRT gene was used as an internal control. A significant difference is indicated by *P < 0.05. ****, Ns = Not significant (0.611). B RP gene was used as an internal control. A significant difference is indicated by *P < 0.05. ****, Ns = Not significant, (0.608).

The Ct value emerged in RT-PCR assay for the SARS-COV-2 Ct-value of E Mean ± SD (min, max) 26 ± 6.53 (14.24, 39.24) Ct-value of N Mean ± SD (min, max) 20.19 ± 5.93 (9.72, 33.82) Ct-value of RDRP Mean ± SD (min, max) 26.92 ± 7.04 (13.85, 40) Ct-value of HPRT Mean ± SD (min, max) 31.34 ± 2.75 (26.94, 40) Ct-value of RP Mean ± SD (min, max) 24.43 ± 1.63 (20.56, 27.94) The ∆Ct value emerged in RT-PCR assay for the SARS-COV-2. E gene Mean ± SD (min, max) −5.34 ± 6.76 (−15.15, 0) 1.57 ± 6.74 (−8.71, 19.07) N gene Mean ± SD (min, max) −11.15 ± 6.28 (−22.45, 0.43) −4.23 ± 6.13 (−13.23, 13.65) RDRP gene Mean ± SD (min, max) −4.42 ± 7.27 (−16.91, 11.42) 2.49 ± 7.32 (−6.84, 17.59) Cycle threshold (Ct) value of qRT-PCR. HPRT gene was used as an internal control. A Comparison of N target and HPRT, B Comparison of E target and HPRT, and C Comparison of RDRP target and HPRT. A significant difference is indicated by *P < 0.05. **** = (< 0.0001). Cycle threshold (Ct) value of qRT-PCR. RP gene was used as an internal control. A Comparison of N target and RP, B Comparison of E target and RP, and C Comparison of RDRP target and RP. A significant difference is indicated by *P < 0.05. **** = (< 0.0001). Comparison of the cycle threshold (∆Ct) value of SARS-COV-2 expression. A HPRT gene was used as an internal control. A significant difference is indicated by *P < 0.05. ****, Ns = Not significant (0.611). B RP gene was used as an internal control. A significant difference is indicated by *P < 0.05. ****, Ns = Not significant, (0.608).

Discussion

In this study, Ct values for the N, RDRP, and E targets were evaluated using qRT-PCR in order to detect SARS-CoV-2 in 100 clinical samples. It was observed that N gene has less Ct values (23.73 ± 6.99) than those of E and RDRP. Moreover, our results show a significant difference among the E, N, and RDRP groups. The diagnosis of SARS-CoV-2 using molecular tests is known as the gold standard method for the diagnosis of COVID-19 infection. Of note, the RT-PCR is a sensitive assay for the detection of SARS-CoV-2 RNA in clinical specimens (Chaimayo et al. 2020). The study showed that after the onset of the disease’s symptoms, the SARS-CoV-2 viral load can be immediately observed in the upper respiratory tract and the antigen can also be detected in the first phase. However, some factors such as clinical manifestations, duration of disease to laboratory test, type of clinical sample, and sample collection procedure (technique process) can be effective on interpreting the results (Zou et al. 2020). In general, many developed laboratory methods use various tools, reagents, and targets in order to identify SRRS-COV-2 (LeBlanc et al. 2020). RDRP, E, and N are three targets proposed by WHO for the SARS-COV-2 identification (Corman et al. 2020a). As well, the E gene is the first line screening, the RDRP gene is used as confirmatory test, and the N gene is used for a confirmatory testing, all of which are used in identifying the coronavirus. A previous study has shown that the RdRP_SARSr-P2 target could be specific for the coronavirus, and other probes are suitable for the detection of other types of coronavirus, and if false positive results are obtained regarding the diagnosis of Covid-19, it may possibly indicate that patients with mild symptoms are infected with other types of corona virus (Kakhki et al. 2020b). Besides, evidence suggests that other targets such as ORF8 and specific primers / probes, may act as additional confirmatory tests in the diagnosis of SARS-COV-2 (kamali Kakhki et al. 2020a). Houda et al. in their study have evaluated three genes of RDRP, N, and E in 187 COVID-19 samples and found gene expression as 22% and 40% in N and N, E genes, respectively. They have also shown that 6% of patients with both E and N genes and 14% of those with N gene still remained positive after a 12-day treatment period (Benrahma et al. 2020). In addition, a study of 114 respiratory specimens has revealed that the N Ct value was more specific for laboratory diagnosis of SARS-CoV-2 (Abbasi et al. 2022). However RT-qPCR has a high levels of specificity and sensitivity, but sensitivity of COVID-19 RT-PCR diagnostic kits could be associated to the specimen conditions such as transportation or storage, sample preservation times, and the quality of the kits (Bezier et al. 2020). COVID-19 RT-PCR diagnostic kits with high analytical specificity and sensitivity could help reduce the impact of false-negative results and significantly improve the identification of COVID-19 patients (Shen et al. 2021). Another study has shown that the one-​step real-time RT-PCR can detect SARS-CoV-2 RNA in clinical specimens with a low detection sensitivity (Michel et al. 2021). Since January 2020, protocols, tests, and reagents have been developed and introduced for the detection of SARS-COV-2. These laboratory tests that use SARS-CoV-2 RNA for the detection of COVID-19, were compared with commercial kits. A previous study using RT-PCR and two primers (N1 and N2) for SARS-COV-2 identification (Shirato et al. 2020) has shown that N2 primer has high specificity and sensitivity in this regard. These primers were also assessed using the following commercial kits: LN S & W-E, LN S & W-N, and LMW & RDRP (Hoehl et al. 2020). The results showed that the commercial LN S & W-N kit containing N primer was able to detect the virus better than the LN S & W-E (25 copies detected) and LMW & RDRP kits. It was observed that the LN S & WE targets are strongly conserved in the E gene region on SARS-COV and SARS-COV-2, while the N2 targets are a single region of N gene on SARS-COV-2 virus, so N2 is highly sensitive and specific for the detection of SARS-CoV-2 (Corman et al. 2020b). This study showed that selection of different targets with high expression lead to increased sensitivity of diagnostic kits, therefore, to reduce false negative results and to increase the sensitivity, diagnostic tests should be designed based on the targets that have the most differential expression. Correspondingly, RT-PCR method using of N, E, and RDRP targets is known as a reliable and accurate method for SARS-CoV-2 identification that can be used in infection’s prevention and control, and in diagnostic laboratories and medical centers.
  24 in total

1.  Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan.

Authors:  Kazuya Shirato; Naganori Nao; Harutaka Katano; Ikuyo Takayama; Shinji Saito; Fumihiro Kato; Hiroshi Katoh; Masafumi Sakata; Yuichiro Nakatsu; Yoshio Mori; Tsutomu Kageyama; Shutoku Matsuyama; Makoto Takeda
Journal:  Jpn J Infect Dis       Date:  2020-02-18       Impact factor: 1.362

2.  Pseudogene-free amplification of HPRT1 in quantitative reverse transcriptase polymerase chain reaction.

Authors:  Reza Valadan; Omolbanin Amjadi; Mohsen Tehrani; Alireza Rafiei; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei
Journal:  Anal Biochem       Date:  2015-06-04       Impact factor: 3.365

3.  Development of a Cost-Effective Line Probe Assay for Rapid Detection and Differentiation of Mycobacterium Species: A Pilot Study.

Authors:  Reza Kamali Kakhki; Ehsan Aryan; Zahra Meshkat; Mojtaba Sankian
Journal:  Rep Biochem Mol Biol       Date:  2020-01

4.  Prevalence and genetic diversity analysis of human coronavirus OC43 among adult patients with acute respiratory infections in Beijing, 2012.

Authors:  Qin Hu; Roujian Lu; Kun Peng; Xijie Duan; Yanqun Wang; Yanjie Zhao; Wen Wang; Yongliang Lou; Wenjie Tan
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

6.  Comparison of four commercial RT-PCR diagnostic kits for COVID-19 in China.

Authors:  Lingyu Shen; Shujuan Cui; Daitao Zhang; Changying Lin; Lijuan Chen; Quanyi Wang
Journal:  J Clin Lab Anal       Date:  2020-12-15       Impact factor: 2.352

7.  Data supporting the design and evaluation of a universal primer pair for pseudogene-free amplification of HPRT1 in real-time PCR.

Authors:  Reza Valadan; Akbar Hedayatizadeh-Omran; Mahdyieh Naghavi Alhosseini-Abyazani; Omolbanin Amjadi; Alireza Rafiei; Mohsen Tehrani; Reza Alizadeh-Navaei
Journal:  Data Brief       Date:  2015-07-06

8.  COVID-19 target: A specific target for novel coronavirus detection.

Authors:  Reza Kamali Kakhki; Mohammad Kamali Kakhki; Alireza Neshani
Journal:  Gene Rep       Date:  2020-05-30

9.  Comparative Analysis of Primer-Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2).

Authors:  Yujin Jung; Gun-Soo Park; Jun Hye Moon; Keunbon Ku; Seung-Hwa Beak; Chang-Seop Lee; Seil Kim; Edmond Changkyun Park; Daeui Park; Jong-Hwan Lee; Cheol Woo Byeon; Joong Jin Lee; Jin-Soo Maeng; Seong-Jun Kim; Seung Il Kim; Bum-Tae Kim; Min Jun Lee; Hong Gi Kim
Journal:  ACS Infect Dis       Date:  2020-08-29       Impact factor: 5.084

10.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.